GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Insulet Corp (FRA:GOV) » Definitions » Cyclically Adjusted PB Ratio

Insulet (FRA:GOV) Cyclically Adjusted PB Ratio : 47.73 (As of May. 22, 2025)


View and export this data going back to 2007. Start your Free Trial

What is Insulet Cyclically Adjusted PB Ratio?

As of today (2025-05-22), Insulet's current share price is €286.40. Insulet's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was €6.00. Insulet's Cyclically Adjusted PB Ratio for today is 47.73.

The historical rank and industry rank for Insulet's Cyclically Adjusted PB Ratio or its related term are showing as below:

FRA:GOV' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 24.95   Med: 61.99   Max: 118.98
Current: 50.01

During the past years, Insulet's highest Cyclically Adjusted PB Ratio was 118.98. The lowest was 24.95. And the median was 61.99.

FRA:GOV's Cyclically Adjusted PB Ratio is ranked worse than
99.8% of 496 companies
in the Medical Devices & Instruments industry
Industry Median: 1.84 vs FRA:GOV: 50.01

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Insulet's adjusted book value per share data for the three months ended in Mar. 2025 was €17.494. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €6.00 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Insulet Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Insulet's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Insulet Cyclically Adjusted PB Ratio Chart

Insulet Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 104.69 83.35 75.20 47.21 43.63

Insulet Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 35.06 38.60 41.58 43.63 40.47

Competitive Comparison of Insulet's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, Insulet's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Insulet's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Insulet's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Insulet's Cyclically Adjusted PB Ratio falls into.


;
;

Insulet Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Insulet's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=286.40/6.00
=47.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Insulet's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Insulet's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=17.494/134.9266*134.9266
=17.494

Current CPI (Mar. 2025) = 134.9266.

Insulet Quarterly Data

Book Value per Share CPI Adj_Book
201506 1.101 100.684 1.475
201509 0.863 100.392 1.160
201512 0.549 99.792 0.742
201603 0.415 100.470 0.557
201606 0.427 101.688 0.567
201609 1.010 101.861 1.338
201612 1.042 101.863 1.380
201703 1.027 102.862 1.347
201706 0.992 103.349 1.295
201709 1.071 104.136 1.388
201712 2.297 104.011 2.980
201803 2.356 105.290 3.019
201806 2.600 106.317 3.300
201809 2.872 106.507 3.638
201812 3.150 105.998 4.010
201903 3.319 107.251 4.175
201906 3.675 108.070 4.588
201909 2.213 108.329 2.756
201912 1.090 108.420 1.356
202003 0.847 108.902 1.049
202006 7.625 108.767 9.459
202009 7.669 109.815 9.423
202012 7.516 109.897 9.228
202103 7.425 111.754 8.965
202106 5.554 114.631 6.537
202109 6.140 115.734 7.158
202112 7.117 117.630 8.164
202203 5.851 121.301 6.508
202206 5.759 125.017 6.216
202209 6.226 125.227 6.708
202212 6.470 125.222 6.971
202303 6.738 127.348 7.139
202306 7.324 128.729 7.677
202309 8.152 129.860 8.470
202312 9.611 129.419 10.020
202403 10.389 131.776 10.637
202406 13.229 132.554 13.466
202409 14.361 133.029 14.566
202412 16.484 133.157 16.703
202503 17.494 134.927 17.494

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Insulet  (FRA:GOV) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Insulet Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Insulet's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Insulet Business Description

Traded in Other Exchanges
Address
100 Nagog Park, Acton, MA, USA, 01720
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide.

Insulet Headlines

No Headlines